NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), a company developing advanced artificial intelligence solutions for clinical trial optimization and ...

Non-Hodgkin lymphoma (NHL) is a group of hematologic malignancies that originate from lymphocytes known as B or T cells. This ...

New York Blood Center Enterprises’ (NYBCe) Lindsley F. Kimball Research Institute (LFKRI) today announced a scientific collaboration with Biohub to develop optimized methodologies for deriving induced ...

Amid the flurry of capital flowing into data center ABS deals in the US, Standard & Poor’s should be lauded for maintaining ...

People with meniscus tears who underwent surgery had poorer knee function and worse osteoarthritis after 10 years than those who did not ...

Launchpad Build AI says its Manufacturing Language Model can democratize automation for high-mix, low-volume production with ...

Two years in, Albertans are less impressed with Nenshi than they used to be. And Albertans of almost every type are more ...

Orca Bio’s Orca-Q receives US FDA’s RMAT designation for treatment of high-risk hematologic malignancies: Menlo Park, California Thursday, April 30, 2026, 18:00 Hrs [IST] Orca ...

Median overall survival exceeded SEER benchmarks by 2 months in metastatic NSCLC and 8 months in de novo metastatic breast ...

OPKO Health, Inc. (NASDAQ: OPK) (OPKO) reports business highlights and financial results for the three months ended March 31, 2026. Highlights from the first ...

By David Bautz, PhD NASDAQ: SNGX READ THE FULL SNGX RESEARCH REPORT Business Update FLASH2 Trial Recommended to Stop for Futility On April 28, 2026, Soligenix, Inc. (NASDAQ: SNGX) announced interim ...

For our Know Your Niche series, Steve Mason, with Bank of America's Private Bank, has developed a client base out of horse ...